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INTRODUCTION
Diffuse liver cell damage can develop due to many causes
including overwhelming viral infection, superinfection with
a second virus, microcirculatory failure, and various drugs
and toxins (1). Sequential pathophysiological responses to
diffuse liver cell necrosis have been well documented. Cellu-
lar kinetics of hepatic stellate cells (HSCs) in association
with hepatic fibrogenesis and stem cells with hepatic regen-
eration have been carefully elucidated mostly in animal
models (2, 3). There are fewer studies dealing with these
responses in human liver because it is practically difficult to
obtain and ethically improper to manipulate human tissues
at different time courses of liver regeneration. Since liver
transplantation has become a popular therapeutic modality
for acute or chronic liver cell damage, failed liver explants
or a native liver in auxiliary partial orthotopic liver trans-
plantation are available at different stages of liver regenera-
tion (4).
It has been suggested that liver regeneration can occur
either by differentiated adult hepatocytes which retain the
capability for several rounds of replication or by hepatic
progenitor (stem) cells, depending on the type of the injuri-
ous agent, the nature of liver disease or the number of hepa-
tocytes lost (5). Direct stimuli leading to proliferation of
parenchymal cells and the mechanisms of liver regeneration,
however, have not been clearly demonstrated. Previously
overlooked to a great extent, nonparenchymal cells are
emerging as major regulators in intermediary metabolism,
growth, and response to injury of hepatocytes. Thus the
interaction between parenchymal and nonparenchymal cells
is essential in a wide variety of physiologic and pathologic
responses in hepatic regeneration (6). Many cytokines pro-
duced by nonparenchymal cells or hepatocytes may pro-
mote or inhibit hepatocyte or nonparenchymal cell growth
(7, 8), and HSCs play an important role in hepatic fibrogen-
esis (9, 10). In addition to various liver diseases, primary
nonfunctioning allograft is an excellent human model of
diffuse liver cell necrosis in which the onset of liver failure is
clearly defined, i.e., at the time of transplantation (11).
In this study, we describe diverse cellular responses in
explanted livers due to acute and chronic liver cell damage
of variable duration. In early stage of regeneration, influx or
proliferation of nonparenchymal cells including CD68-posi-
Ghil-Suk Yoon, Arief Suriawinata*, 
Swan N Thung*, Eunsil Yu 
Departments of Pathology, Asan Medical Center, 
University of Ulsan College of Medicine, Seoul, Korea;




Department of Pathology, University of Ulsan College
of Medicine, Asan Medical Center, 388-1 Poongnap-
dong, Songpa-gu, Seoul 138-736, Korea
Tel : +82.2-2224-4552, Fax : +82.2-472-7898
E-mail : esyu@www.amc.seoul.kr
439
J Korean Med Sci 2001; 16: 439-47
ISSN 1011-8934
Copyright � The Korean Academy
of Medical Sciences
Parenchymal and Nonparenchymal Cellular Responses in Human 
Hepatic Regeneration
To characterize cellular responses during hepatic regeneration, we examined 13
explant livers and 5 liver allografts by immunohistochemistry for cytokeratin 7,
HepPar1, CD68,  -smooth muscle actin ( -SMA) and proliferating cell nuclear
antigen as well as reticulin and Masson-trichrome staining. Within a week after
liver damage, elongated CD68-positive cells were detected along the border of
necrotic area. The number of  -SMA-positive cells was slightly increased along
the sinusoids. Ductular proliferation or fibrosis was negligible. After one or two
weeks, the size and number of CD68-positive cells were markedly increased.  -
SMA-positive cells increased in number within lobules and portal tracts. Ductular
proliferation occurred predominantly at the limiting plate or along the border of
necrotic areas. After one month, necrotic parenchyma was replaced by many
ductules, CD68-positive cells,  -SMA-positive cells. Nodules of regenerating hep-
atocytes and irregular fibrosis were diffusely present. Other nonparenchymal
cells were not significantly changed. These observations indicate that chronologi-
cal interaction between nonparenchymal and parenchymal cells occur during the
course of human hepatic regeneration and suggest extensive porto-periportal
fibrosis more than a few months after the onset of fulminant hepatitis is a major
indicator of chronic functional impairment necessitating liver transplantation.
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tive cells was predominant. During hepatic regeneration,
small parenchymal cells in ductular arrangement increased
prominently and some of them appreared to transform to
hepatocytes in later stage. These cellular responses in human
livers mirror sequential changes in animal models of mas-
sive hepatic necrosis and appear to be associated with time
course after diffuse liver cell damage rather than the etiolo-
gy of liver cell damage. Furthermore marked increase in
number of intralobular HSCs and portal myofibroblasts
may be closely related with irreversible hepatic fibrogenesis
leading to liver transplantation compared with chronologi-
cal histopathologic changes that were observed in complete-
ly regenerated native liver (4).
MATERIALS AND METHODS
Cases
Formalin-fixed, paraffin-embedded tissues from 13 livers
that were explanted because of fulminant hepatic failure
and 5 liver allografts because of primary nonfunctioning
were selected from the files of the Department of Diagnos-
tic Pathology at the Asan Medical Center, Seoul, Korea.
Liver explants were obtained 1 day to over 1 yr after the
onset of fulminant hepatitis. Preoperative clinical diagnosis
and duration from the onset of jaundice or hepatic encepha-
lopathy until the operation are summarized in Table 1.
Explanted livers were grossly examined and representa-
tive sections were taken from necrotic as well as viable areas.
Serial sections were cut at a thickness of 4-6  m and stained
with hematoxylin and eosin for routine light microscopy.
Reticulin staining was performed to evaluate the status of
hepatic reticulin framework, and Massontrichrome staining
to grade intralobular as well as portal fibrosis.
Immunohistochemistry
Parellel sections were stained with a panel of 5 primary
antibodies: anti-CD68 (DAKO, Carpinteria, CA, U.S.A.),
anti-CK7 (DAKO), HepPar 1 (12), anti- -SMA (DAKO), and
anti-proliferating nuclear antigen (anti-PCNA, DAKO)
antibodies. CD68 is a marker for circulating macrophages
and Kupffer cells in the liver. CK7 is exclusively expressed
in bile duct epithelium.  -SMA has been used as a marker
of activated HSCs. These antibodies were employed using
an avidin biotin complex (DAKO LSAB kit). Diaminoben-
zidine in PBS with 0.3% v/v hydrogen peroxide was used as
a chromogen. All of the slides were counterstained with
Harris hematoxylin.
All of the fields in the slides were examined and assessed
in terms of spatial relationship between parenchymal and
nonparenchymal cells.
RESULTS
Thirteen cases of liver explants that were removed during
transplantation showed diverse histopathologic features in
viable areas. We could not detect any specific histopatho-
logic features indicating underlying liver diseases. But five
cases of primary nonfunctioning allograft displayed either
periportal or centrilobular hepatocellular ischemic necrosis
only. We selected the sections with representative histo-
pathologic features and categorized 18 explanted liver ten-
tatively into 3 groups according to the duration since the
first episode of fulminant hepatic failure as follows: group 1,
within a few days (<7 days) as in 5 cases of liver allograft
with primary nonfunctioning; group 2, from 1 to 4 weeks;
group 3, more than 1 month. In all cases, there was no evi-
dence of acute rejection.
Reticulin framework of the liver
The reticulin framework was intact in cases of group 1,
although parenchymal necrosis was diffuse. In some cases of
group 2, multifocal collapse of the reticulin framework
within the lobule was detected in either necrotic areas or
viable parenchyma. In most cases of group 3, condensation
of reticulin fibers was observed multifocally where cellular
components distributed sparsely.
Distribution of CD68-positive cells
In cases of group 1, CD68 positive cells were identified
mostly along the border of necrotic area and partly in the
1 Primary graft nonfunctioning 2 days
2 Primary graft nonfunctioning 2 days
Group 1 3 Primary graft nonfunctioning 2 days
4 Primary graft nonfunctioning 3 days
5 Primary graft nonfunctioning 4 days
6 Unknown 1 week
7 Drug-induced toxic hepatitis 10 days
Group 2 8 Unknown 2 weeks
9 Drug-induced toxic hepatitis 3 weeks
10 Wilson's disease 3 weeks
11 Drug-induced toxic hepatitis 3 weeks
12 Unknown 1 month
13 HBV infection 1 month
14 Drug-induced toxic hepatitis 6 weeks
Group 3 15 Drug-induced toxic hepatitis 3 months
16 Drug-induced toxic hepatitis 4 months
17 Drug-induced toxic hepatitis 8 months
18 Budd-Chiari syndrome >1 yr
Duration* Case No. Etiology
Table 1. Summary of 18 cases examined in this study
*time interval from the first episode of fulminant hepatic failure until the
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sinusoid of the necrotic area (Fig. 1A). Most CD68-positive
cells were in elongated shape with slender cytoplasms. In
cases of group 2, CD68-positive cells were present diffusely
in necrotic areas (Fig. 1B) and became polygonal with
plump cytoplasm (Fig. 1C). The number and distribution
pattern of CD68-positive cells were similar in cases of
group 3.
Distribution of CK7-positive cells and HepPar 1-posi-
vite cells
In cases of group 1, the number of bile ducts was not
increased, while singly scattered cells or a few clusters of
cells adjacent to limiting plates were strongly positive for
CK7 (Fig. 2A). In cases of group 2, CK7-positive cells were
arranged in irregular shaped ductules, and were mostly
located at the border of necrotic areas (Fig. 2B). In cases of
group 3, there were two types of epithelial cells: CK7+/
CAM5.2+cells and CK7-/CAM5.2+cells (data not shown).
CK7-positive cells were much more widely distributed and
were arranged mostly in ductular structure (Fig. 2C). In
cases of group 1, viable hepatocytes were weakly positive by
HepPar 1 (Fig. 3A). In cases of group 2, no epithelial cells
were positive by HepPar 1, while in cases of group 3,
grouped small regenerating epithelial cells were positively
stained by HepPar 1 (Fig. 3B). Some of CK7-positive cells
abutted on HepPar1-positive cells that had plump cyto-
plasm and multiple nuclei with prominent nucleoli (Fig. 4). 
C
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Fig. 1. Immunohistochemistry for CD68. Most of CD68-positive
cells are located along the sinusoid and have elongated cyto-
plasm in group 1 (A) (×100), while they distribute diffusely in
late stage (B) (×100). CD68-positive cells in late stage of hep-
atic regeneration are enlarged and polygonal (C) (×400).442 G.-S. Yoon, A. Suriawinata, S.N. Thung, et al.
Distribution of  -SMA-positive cells and fibrosis
In cases of group 1,  -SMA-positive cells were rarely
detected in necrotic areas (Fig. 5A). They were flat with
dendritic cytoplasmic processes and were located along the
sinusoidal spaces. Within the portal tracts,  -SMA-positive
cells were infrequently present. In cases of group 2, the
number of  -SMA-positive cells was markedly increased,
and most of  -SMA-positive cells were present within the
lobules (Fig. 5B). In cases of group 3, the number of  -
SMA-positive cells was markedly increased in areas of retic-
ulin condensation within the lobule as well as portal areas
where fibrosis was markedly advanced (Fig. 5C).
Distribution of PCNA-positive cells
In all primary nonfunctioning allografts, more than 90%
of viable hepatocytes were strongly positive for PCNA, but
cells in portal tracts were negative for PCNA (Fig. 6A). In
cases of group 2, more than half of cells were strongly
posivite for PCNA (Fig. 6B). Mitotic figures were occasion-
ally present. A few PCNA-positive cells had elongated
nuclei, which were suggestive of nonparenchymal cells (data
not presented). In cases of group 3, the number of PCNA-
positive cells was markedly decreased and the cells in portal
tracts were mostly negative for PCNA (Fig. 6C).
C
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Fig. 2. Immunohistochemisty for CK7. In addition to normal bile
ducts, a few CK7-positive cells (arrows) appear at the limitin
plaste of portal tract in cases of group 1 (A) (×400). Proliferat-
ing bile ductules are present at the border of necrotic areas in
cases of group 2 (B) (×100). In cases of group 3, ductular pro-
liferation is prominent (C) (×40).Cellular Responses in Human Hepatic Regeneration 443
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Fig. 3. Immunohistochemistry by HepPar1. In cases of group 1, viable hepatocytes are weakly positive (A) (×40). Irregularly arran-
ged regenerating epithelial cells are positive in cases of group 3 (B) (×200).
A B
Fig. 4. Immunohistochemisty for CK7 (A) and HepPar1 (B) in cases of group 3 (×400). CK7-positive cells abut on HepPar 1-positive 
large multinucleated regeneratin hepatocytes.
DISCUSSION
In order to analyze cellular responses during hepatic
regeneration, it is ideal to examine serial histopathologic
features in the same cases. However, it was impossible in
human cases ethically as well as practically due to the limi-
tation of obtaining the samples. Thus broad spectrum of
histopathologic changes during hepatic regeneration have
been rarely documented in human livers (4, 11, 13, 14).
We selected cases of fulminant hepatic failure without
any specific histopathologic features in association with the
etiologies, but with common histopathologic changes only
in terms of the time interval between the onset of acute
hepatic failure and liver transplantation. Thus, diverse cel-
lular responses in our cases may be related to the duration
since the onset of diffuse liver damage.444 G.-S. Yoon, A. Suriawinata, S.N. Thung, et al.
We examined primary nonfunctioning liver allografts in
which liver injury presumably occurred at the time of liver
transplantation because they are excellent models for early
phase of hepatic regeneration. In the early phase of hepatic
regeneration, the most prominent feature was that number
of CD68-positive cells increased moderately along the bor-
der of the necrotic area and slightly in the sinusoid of the
necrotic areas. Most of the CD68-positive cells within the
necrotic areas are considered Kupffer cells on the basis of
their location and morphologic characteristics such as elon-
gated cytoplasm (15-17). However, a possibility that
migrated macrophages might participate in the tissue reac-
tion during hepatic regeneration can not be excluded,
because necrotic hepatic parenchyma was filled with blood
cells. In rats in which cross-sex or cross-strain bone marrow
transplantation and hepatic injury using 2-acetylaminofluo-
rene and CCl4 protocol were performed, a proportion of
regenerated hepatic cells were shown to be derived from the
donor bone marrow stem cells (18). Thus, presence of bone
marrow stem cells needs to be examined to evaluate the
possibility of hepatic stem cells of bone marrow origin in
human cases of massive hepatic necrosis.
The marked increase in PCNA-positive hepatocytes in
early hepatic regeneration indicates that they are activated
to repair intracellular damage as well as prepare to replicate
because PCNA is involved in DNA repair and replication
(13, 19-21). Sinusoidal PCNA-positive cells are considered
to be activated Kupffer cells or macrophages on the basis of
C
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Fig. 5. Immunohistochemisty for  -SMA. Stellate-shaped cells
are rarely scattered in the lobule and portal tracts in cases of
group 1 (A) (×40), while intralobular  -SMA-positive cells in-
creased diffusely in cases of group 2 (B) (×100). In cases of
group 3,  -SMA-positive cells increased in the portal tract, as
well (C) (×100).Cellular Responses in Human Hepatic Regeneration 445
their location and nuclear shape as indicated previously
(19). Frequent mitotic figures in ductules that were pre-
sent mostly at the limiting plates indicated that they
might actively proliferate from hepatic stem cells. In late
stage of hepatic regeneration, PCNA immunostaining
decreased markedly and was confined within the hepato-
cytes. These sequential changes of the type of proliferating
cells indicate that there should be a cross talk signaling cell
proliferation between nonparenchymal and parenchymal
cells.
We used CK7 and HepPar1 as a marker for parenchymal
cells to evaluate their topological characteristics. CK7-posi-
tive cells along the interface of portal tracts were considered
to be either progenitor cells or intermediate cells rather
than bile duct cells on the basis of their cellular characteris-
tics and immature organization. Both CK7- and HepPar1-
positive cells in cases of group 3 may correspond to ductular
hepatocytes (DHs) which are also known under the term
lbiliary hepatocytes’ , ‘transitional cells’ , ‘hepatocyte-like
cells’ , ‘neocholangioles’ , or ‘oval cells’ (11, 14, 22-26). Fujita
et al. (4) observed single regenerating hepatocyte first 2
months after the onset of fulminant hepatitis in native liver
after auxillary partial orthotopic liver transplantation. On
the basis of our observations, however, regeneration of liver
cells appears to begin earlier at least 1 month after diffuse
hepatic necrosis. 
With progression of hepatic regeneration, reticulin frame-
work was progressively collapsed, which was strongly corre-
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Fig. 6. Immunohistochemistry for PCNA. Most of viable hepato-
cytes are immunostained for PCNA in group 1 (A) (×100). More
than half of irregularly arranged epithelial cells are strongly im-
munostained for PCNA in a case of group 2 (B) (×100). In a
case of group 3, PCNA-positive cells decreased markedly both
in the lobule and the portal tract (C) (×100).
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lated with the proliferation of  -SMA-positive cells and
deposition of collagen fibers.  -SMA-positive cells were dis-
tributed either within hepatic lobules or portal tracts. In
acute liver injury following administration of CCl4 and other
toxins, the HSC may migrate into or actively proliferate
predominantly in necrotic areas. In contrast, in models of
chronic injury, progressive expansion of HSC population
was mainly seen within fibrous septa as we described in
cases of the late regenerative phase (27, 28). In the case of
complete regeneration after massive hepatic necrosis with-
out residual fibrosis, no increase of  -SMA-positive cells has
been described (4), but fibrosis around the reorganized hep-
atic trabeculae at 6 months might be associated with
intralobular  -SMA-positive cells. Thus, increase in  -
SMA-positive cells in portal tracts and irregular fibrosis
more than a month after the first episode of hepatic failure
may be an indicator of irreversible hepatic fibrogenesis.
On the basis of the observation in the present study, a
schematic sequence of events is suggested that CD68-posi-
tive cells are firstly involved very early following diffuse
liver cell necrosis and then both HSCs and CK7-positive
cells increase in number within a few weeks. Some CK7-
positive cells are phenotypically transformed to hepatocytes
1 month after the onset of fulminant hepatitis. Increase of
myofibroblasts in portal tracts in later phase of hepatic
regeneration may cause irreversible hepatic fibrogenesis,
while intralobular  -SMA may participate in forming
intact perisinusoidal framework in cases of complete regen-
eration (Fig. 7). These parenchymal and nonparenchymal
cellular responses against diffuse hepatic damage mirror the
changes in experimental animal models of massive hepatic
necrosis and appear to occur irrespectively to the etiology.
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